Dr. Tarik Hadid Provides Comprehensive and Personalized Oncology Care in Detroit and Warren, MI
| NASHVILLE, Tenn., Dec. 19, 2018 /PRNewswire/ -- Verdi Oncology, Inc., an oncology practice and clinical research management company, announced today it has partnered with Dr. Tarik Hadid to open Verdi Cancer & Research Center of Macomb, Michigan. The new location marks Verdi’s entry into the state of Michigan, and the first acquisition since partnering with Horizon Oncology in Lafayette, Indiana earlier this year. Verdi focuses on partnering with both existing community oncology practices looking to enhance their operations and high-quality oncology physicians interested in opening new Verdi-affiliated practices to gain autonomy and practice management excellence. Verdi provides the resources, management expertise, and economies of scale to build out the infrastructure necessary for community oncology to thrive in today’s evolving healthcare and value-based care environment.
Dr. Hadid said, “I am thrilled to partner with Verdi on opening this new location. As I evaluated my practice options, Verdi was the best partner for me not only given the support and resources they provide but also our shared patient-first philosophy. I am confident that being a part of the Verdi network will make it easier for me to focus on my patients and provide them with the highest level of care.” Wes Chapman, CEO of Verdi, said, “We are pleased to welcome Dr. Hadid to the Verdi platform, as we aim to ensure a better patient experience while dedicating financial and operational resources that will help him continue building a successful practice.” To learn more about partnership opportunities with Verdi Oncology, please contact Henry Varnell, Director of Corporate Development, at 615-270-1905 or hvarnell@verdioncology.com.
About Tarik Hadid, MD, MPH, MS, FACP About Verdi Oncology, Inc. Contact
SOURCE Verdi Oncology, Inc. |
View original content:
